WESCAP-PN DHA- ascorbic acid, cholecalciferol, .alpha.-tocopherol, d-, pyridoxine hydrochloride, levomefolate calcium, folic acid, cyanocobalamin, calcium carbonate, ferrous fumarate, magnesium oxide, and doconexent capsule, gelatin coated

WesCap-PN DHA by

Drug Labeling and Warnings

WesCap-PN DHA by is a Other medication manufactured, distributed, or labeled by Westminster Pharmaceuticals, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

STATEMENT OF IDENTITY

Supplement Facts
Serving Size: 1 Softgel
Amount Per Serving	% Daily Value for Pregnant and Lactating Women
* From at least 330 mg purified fish oil † Daily Value not established
Vitamin C (ascorbic Acid)	85 mg	71%
Vitamin D (Vitamin D3 as Cholecalciferol)	5 mcg (200 IU)	33%
Vitamin E (d-alpha tocopherol)	6.7 mg (10 IU)	35%
Vitamin B6 (pyridoxine HCl)	25 mg	1250%
Folate (L-Methylfolate Calcium, or 6(S)-5-MTHF-Ca 600 mcg) (folic acid, USP 400 mcg)	1700 mcg DFE (400 mcg Folic Acid)	283%
Vitamin B12 (cyanocobalamin)	12 mcg	429%
Calcium (calcium carbonate)	140 mg	11%
Iron (ferrous fumarate)	27 mg	100%
Magnesium (magnesium oxide)	45 mg	11%
Docosahexaenoic Acid (DHA)	300 mg*	†

Other Ingredients: Gelatin, Soybean Oil, Glycerin, Purified Water, Soy Lecithin, Titanium Dioxide, Yellow Beeswax, Natural Creamy Orange Flavor, FD&C Yellow #6, Ethyl Vanillin, FD&C Red #40.

DESCRIPTION

WesCap-PN DHA is a prescription prenatal/postnatal multivitamin/mineral dietary supplement with fishbased DHA and should be administered under the supervision of a licensed medical practitioner.

DOSAGE AND ADMINISTRATION

Before, during and/or after pregnancy, one softgel daily or as directed by a licensed healthcare practitioner regardless of lactation status.

CAUTION

Ingestion of more than 3 grams per day of omega-3 fatty acids (ALA, EPA, and DHA) may have potential antithrombotic activities, or effects, and may increase bleeding times. Administration of omega-3 fatty acids, including DHA, should be avoided in patients with inherited or acquired bleeding diathesis, including those taking anticoagulants. Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) per day.

WARNINGS

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

CAUTION

High levels of folic acid may, especially in older adults, hide signs of Vitamin B-12 deficiency (such as pernicious anemia), a condition that can cause nerve damage.

STORAGE

Store at 20° to 25°C (68° to 77°F). Excursions permitted to 15° to 30°C (59° to 86°F). Protect from light and moisture. Dispense in a tight, light-resistant container.

HEALTH CLAIM

Call your licensed medical practitioner about side effects. You may report side effects by calling Westminster Pharmaceuticals LLC, at 1-844-221-7294 or FDA AT 1-800-FDA-1088.

HOW SUPPLIED

Supplied as oblong, orange-colored softgel, imprinted "316" and dispensed in 30 count bottles.

HEALTH CLAIM

Manufactured for:
Westminster Pharmaceuticals, LLC
Nashville, TN 37217
Rev. 09/21

PRINCIPAL DISPLAY PANEL - 30 Softgel Bottle Label

69367-316-30
Rx

WesCap-PN DHA

PRENATAL/POSTNATAL

Prescription Multivitamin/Mineral
Dietary Supplement with
Fish-Based DHA

30 Softgels

Westminster
Pharmaceuticals

INGREDIENTS AND APPEARANCE

WESCAP-PN DHA 
ascorbic acid, cholecalciferol, .alpha.-tocopherol, d-, pyridoxine hydrochloride, levomefolate calcium, folic acid, cyanocobalamin, calcium carbonate, ferrous fumarate, magnesium oxide, and doconexent capsule, gelatin coated

Product Information
Product Type	DIETARY SUPPLEMENT	Item Code (Source)	NHRIC:69367-316
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R)	ASCORBIC ACID	85 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41)	CHOLECALCIFEROL	200 [iU]
.ALPHA.-TOCOPHEROL, D- (UNII: N9PR3490H9) (.ALPHA.-TOCOPHEROL, D- - UNII:N9PR3490H9)	.ALPHA.-TOCOPHEROL, D-	10 [iU]
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z)	PYRIDOXINE	25 mg
LEVOMEFOLATE CALCIUM (UNII: A9R10K3F2F) (LEVOMEFOLIC ACID - UNII:8S95DH25XC)	LEVOMEFOLIC ACID	600 ug
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)	FOLIC ACID	400 ug
CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204)	CYANOCOBALAMIN	12 ug
CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB)	CALCIUM CATION	140 mg
FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR)	FERROUS CATION	27 mg
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838)	MAGNESIUM CATION	45 mg
DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC)	DOCONEXENT	300 mg

Inactive Ingredients
Ingredient Name	Strength
YELLOW WAX (UNII: 2ZA36H0S2V)
SOYBEAN OIL (UNII: 241ATL177A)
GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
GLYCERIN (UNII: PDC6A3C0OX)
WATER (UNII: 059QF0KO0R)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)
ETHYL VANILLATE (UNII: V38JK4Z93O)
FD&C RED NO. 40 (UNII: WZB9127XOA)
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NHRIC:69367-316-30	30 in 1 BOTTLE, PLASTIC

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
DIETARY SUPPLEMENT		12/14/2021

Supplement Facts
Serving Size :		Serving per Container :
	Amount Per Serving	% Daily Value
color
scoring	1
shape
size (solid drugs)	13 mm
imprint

Labeler - Westminster Pharmaceuticals, LLC (079516651)